295 related articles for article (PubMed ID: 21150787)
1. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of genetic testing in adults with a history of venous thromboembolism.
Segal JB; Brotman DJ; Emadi A; Necochea AJ; Samal L; Wilson LM; Crim MT; Bass EB
Evid Rep Technol Assess (Full Rep); 2009 Jun; (180):1-162. PubMed ID: 20629476
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
[TBL] [Abstract][Full Text] [Related]
4. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
Federici EH; Al-Mondhiry H
Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
[TBL] [Abstract][Full Text] [Related]
5. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
[TBL] [Abstract][Full Text] [Related]
6. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
7. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
9. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
[TBL] [Abstract][Full Text] [Related]
14. Direct-to-consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience.
Elson SL; Furlotte NA; Hromatka BS; Wilson CH; Mountain JL; Rowbotham HM; Varga EA; Francke U
Mol Genet Genomic Med; 2020 Nov; 8(11):e1468. PubMed ID: 32940023
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Roy DC; Wang TF; Carrier M; Mallick R; Burger D; Hawken S; Wells PS
J Thromb Haemost; 2023 Nov; 21(11):3184-3192. PubMed ID: 37536569
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
18. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
